Psychosocial Care During the COVID-19 Pandemic in Acute Hospitals
Psychosocial Care During the COVID-19 Pandemic in Acute Hospitals - an International Online Survey of Psychosomatic, Psychiatric and Psychological Consultation and Liaison (C&L) Services
調査の概要
詳細な説明
Background:
The COVID-19 pandemic raised new challenges in supporting patients, relatives and staff for psychosomatic, psychiatric and psychological C&L services in general hospitals worldwide. It is intended to build upon the experience gained so far in order to be well prepared for the future.
Objectives:
The aims of this international online survey are
- To summarize the efforts made in psychosocial care in the context of the COVID-19 pandemic.
- To assess the experiences made with the established services so far.
- To assess the need for networking, cooperation and support.
- Improvement of psychosocial care in acute hospitals in the context of pandemics.
Study Design:
This health services research project will be carried out as an observational study in the form of an international cross-sectional online survey.
There will be one survey time point. Study reporting will follow the STROBE Statement (Strengthening the Reporting of Observational Studies in Epidemiology).
Ethic approval:
In all participating countries the respective ethics committees were informed about the survey and it was checked with them, how far and what kind of country-specific vote of an ethics committee was necessary. Written statements, declarations or votes were obtained from all participating countries.
Setting:
The heads of all psychosomatic, psychiatric and psychological C&L services in acute care hospitals across all participating countries are contacted and asked to participate. Contact is made via the respective national professional societies and relevant working and interest groups.
Participants This study is an international online survey with psychosomatic, psychiatric and psychological C&L services from 14 European countries (Austria, Belgium, Finland, Germany, France, Greece, Ireland, Italy, Norway, Poland, Portugal, Spain, Switzerland, United Kingdom) as well as parts of Canada (Quebec and Ontario region) and Iran participating.
Country specific regions:
The national coordinators of the participating country provided lists of specific regions for their respective country following the NUTS logic (Nomenclature of Territorial Units for Statistics; https://en.wikipedia.org/wiki/Nomenclature_of_Territorial_Units_for_Statistics), preferably a NUTS level that leads to 5 - 20 NUTS for each country.
Online survey questionnaire:
Self-developed questionnaire based on relevant literature, own experience and consultation with participating professional societies. The survey contains 25 questions on structural and process variables regarding characterization of the participating C&L services, involvement of the respective hospitals in the physical care of COVID-19 patients, structures / organization of psychosocial care for COVID-19 patients in the participating hospitals, specific psychosocial support for patients, relatives and staff established in the participating hospital in the context of COVID-19, communication - How the different target groups were informed about the COVID-19 related psychosocial support services and offers, burden of the COVID-19 pandemic on the psychosocial C&L teams, needs and wishes for the future.
The study questionnaire was translated by a professional company from German into English, French and Italian. Language harmonization and cultural adaptation followed a modified committee-based approach informed by the European Social Survey (ESS) Round 9 Translation Guidelines. Participants are free to choose the language version to be worked on.
研究の種類
入学 (実際)
連絡先と場所
研究場所
-
-
-
Dublin、アイルランド
- University College Dublin
-
-
-
-
-
Exeter、イギリス
- University of Exeter
-
York、イギリス
- University of York
-
-
-
-
-
Bologna、イタリア、40123
- Bologna University
-
Modena、イタリア、411274
- University of Modena & Reggio Emilia
-
-
-
-
-
Tehran、イラン・イスラム共和国
- University of Medical Sciences, Department of Psychiatry
-
-
-
-
Steiermark
-
Graz、Steiermark、オーストリア、8036
- Medical University of Graz, University Hospital Graz
-
-
-
-
-
Montreal、カナダ
- University of Montreal, Department of Psychosomatic Medicine
-
Toronto、カナダ
- TorontoSinai Health, University of Toronto, Department of Psychiatry
-
-
-
-
-
Thessaloniki、ギリシャ
- Aristotle University Thessaloniki
-
-
-
-
-
Basel、スイス、4002
- University of Basel, Department of Psychiatry (UPK)
-
-
Basel-City
-
Basel、Basel-City、スイス、4031
- University Hospital Basel, Department of Psychosomatic Medicine
-
-
-
-
-
Barcelona、スペイン
- Barcelona University
-
-
-
-
Bayern
-
Nürnberg、Bayern、ドイツ、90419
- Nuremberg Hospital, Department of Psychosomatic Medicine and Psychotherapy
-
-
Nordrhein-Westfalen
-
Köln、Nordrhein-Westfalen、ドイツ、50937
- University Hospital Cologne, Department of Psychosomatics and Psychotherapy
-
-
-
-
-
Oslo、ノルウェー
- Oslo University Hospital
-
-
-
-
-
Oulu、フィンランド、90220
- Oulu University Hospital and University of Oulu
-
-
-
-
-
Paris、フランス
- Université de Paris, Service de Psychiatrie de l'adulte
-
-
-
-
-
Ghent、ベルギー
- Ghent University Hospital, Department of Psychiatry
-
-
-
-
-
Lisboa、ポルトガル
- Hospital de Santa Maria
-
Lisboa、ポルトガル
- Universidade Católica Portuguesa Lisboa
-
-
-
-
-
Wroclaw、ポーランド
- Wroclaw Medical University
-
-
参加基準
適格基準
就学可能な年齢
健康ボランティアの受け入れ
受講資格のある性別
サンプリング方法
調査対象母集団
説明
Inclusion Criteria:
- heads of all psychosomatic, psychiatric and psychological C&L services in acute care hospitals across all participating countries
Exclusion Criteria:
- None
研究計画
研究はどのように設計されていますか？
デザインの詳細
この研究は何を測定していますか？
主要な結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
Structural and process quality of COVID-19 related psychosocial C&L services
時間枠：6 months
|
Data basis for improving quality of COVID-19 related psychosocial C&L services:
|
6 months
|
協力者と研究者
捜査官
- 主任研究者：Rainer Schaefert, Prof. Dr. med.、University Hospital, Basel, Switzerland
出版物と役立つリンク
研究記録日
主要日程の研究
研究開始 (実際)
一次修了 (実際)
研究の完了 (実際)
試験登録日
最初に提出
QC基準を満たした最初の提出物
最初の投稿 (実際)
学習記録の更新
投稿された最後の更新 (実際)
QC基準を満たした最後の更新が送信されました
最終確認日
詳しくは
本研究に関する用語
追加の関連 MeSH 用語
その他の研究ID番号
- Req-2020-00861; th21Schaefert
医薬品およびデバイス情報、研究文書
米国FDA規制医薬品の研究
米国FDA規制機器製品の研究
この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。